<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8F040A04-142E-43C9-BBAA-33D2D726CC93"><gtr:id>8F040A04-142E-43C9-BBAA-33D2D726CC93</gtr:id><gtr:name>The Statens Serum Institute (SSI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62243C99-76D5-422E-9CAA-1560D3C2E5F5"><gtr:id>62243C99-76D5-422E-9CAA-1560D3C2E5F5</gtr:id><gtr:name>Royal Children's Hospital</gtr:name><gtr:address><gtr:postCode>3052</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8F040A04-142E-43C9-BBAA-33D2D726CC93"><gtr:id>8F040A04-142E-43C9-BBAA-33D2D726CC93</gtr:id><gtr:name>The Statens Serum Institute (SSI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62243C99-76D5-422E-9CAA-1560D3C2E5F5"><gtr:id>62243C99-76D5-422E-9CAA-1560D3C2E5F5</gtr:id><gtr:name>Royal Children's Hospital</gtr:name><gtr:address><gtr:postCode>3052</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6CC14352-1A65-4310-A09D-C22136930E6E"><gtr:id>6CC14352-1A65-4310-A09D-C22136930E6E</gtr:id><gtr:firstName>Katie</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Flanagan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190088485"><gtr:id>AD8F3285-BEFE-4823-8BED-A015519EA811</gtr:id><gtr:title>Interaction between live and killed vaccines: effect of DTP combined vaccine on T cell memory after measles vaccination</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190088485</gtr:grantReference><gtr:abstractText>Live vaccines consist of weakened live organisms, and killed vaccines consist of dead bits of organisms or toxins they produce. Vaccines work by stimulating immune responses in the form of T cells, antibodies and soluble substances called cytokines which fight against the vaccine disease if the person is exposed to it in the future. There is evidence that live vaccines (e.g. measles vaccine (MV)) and killed vaccines (e.g. combined diphtheria, tetanus, pertussis vaccine (DTP)) interact with one another. Specifically, live vaccines give beneficial effects other than protecting against the target disease, but killed vaccines cancel these beneficial effects leading to an increase in deaths. The main aim of this study is to investigate how killed vaccines alter the immune response to live vaccines. We will either give DTP with MV or give MV alone at 9 months of age, and look at the effect on the childs immunity. Understanding interactions between commonly used vaccines will ultimately lead to recommendations regarding safer practices in the future, and provide vital information for the introduction of new vaccines.</gtr:abstractText><gtr:technicalSummary>The introduction of routine vaccination in infants in the form of the expanded program on immunisation (EPI) has had an enormous impact on childhood morbidity and mortality, and millions of doses of vaccines are administered each year. However, the current EPI schedules were recommended &amp;gt;20 years ago, and the WHO Strategic Advisory Group of Experts agree that it may be time to review the scientific evidence and revise current immunization schedules. In the developing world routine vaccines are frequently missed or administered in the wrong order, but there is increasing evidence that the order in which live and killed vaccines are administered is important. Specifically, live vaccines (e.g. measles vaccine (MV)) provide beneficial effects other than protecting against the target pathogen, whereas co-administration of killed vaccines (e.g. diphtheria, tetanus, pertussis (DTP)) seems to negate these beneficial effects leading to increased all cause mortality. Moreover, in most of these studies boys and girls seem to behave differently with survival risks / benefits favouring one sex more than the other. The aim of this proposal is to investigate the immunological basis behind these observations.||300 children have been enrolled into a prospective randomised study to either receive their EPI vaccines according to Gambian guidelines; have the third dose of DTP, which is normally given at 4 months, delayed and administered with measles vaccine at 9 months of age; or receive DTP3 alone at 9 months. Boys and girls are randomised separately for later analysis by sex. Memory responses are being tested at 4 weeks and 9 months after the 9 month vaccines to measles vaccine specific and unrelated antigens. Children will then be challenged with MV at 18 months of age in order to mimic a measles virus infection, and 4 week post challenge effector responses will be analysed.|The results will be used to identify markers that might be associated with poor outcomes for use as a practical tool for testing in field studies, including samples from an ongoing large scale randomised trial of DTP / MV interactions in Guinea Bissau. Our study will contribute to the scientific framework for recommending safe EPI practices, and may have direct effects in documenting that DTP should not be given with or after MV. The results will also inform us about potential interactions that might be applied to other vaccine combinations, which is particularly important given the number of new vaccines that are currently being developed.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2983164</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Immunology and Pathology</gtr:department><gtr:description>Monash Plebanski collaboration</gtr:description><gtr:id>182508A0-F9B3-4589-A4DD-E22294869520</gtr:id><gtr:impact>1 publication - Clinical Immunology 2013; 149(1): 97-110</gtr:impact><gtr:outcomeId>XorvgP9uZca-1</gtr:outcomeId><gtr:partnerContribution>We have 2 joint PhD students. Have recently hosted a Gambian student in the lab. Have publised 1 paper together, writing more papers and a grant.</gtr:partnerContribution><gtr:piContribution>A collaboration with Prof. Magdalena Plebanski, head of the Vaccine and Infectious Diseases Laboratory in the Dept of Immunology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Children's Hospital Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Curtis NHMRC Collaboration</gtr:description><gtr:id>18D2E64C-98B0-4356-BD97-BA9EB5BC233B</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>RTBeZ9zGn6L-1</gtr:outcomeId><gtr:partnerContribution>Co-CIs, study is being set up in Melbourne</gtr:partnerContribution><gtr:piContribution>Chief investigator on NHMRC grant to conduct a prospective BCG vaccine trial in Melbourne</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bandim Health Project (BHP)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Bandim Health Project</gtr:description><gtr:id>0147E069-C776-46A7-9450-97E38FDFB95E</gtr:id><gtr:impact>The award of an EU grant in 2010 to study the non-specific effects of vaccines on mortality in 3 countries in West Africa. MRC Gambia will conduct immunological assays and provide immunologiucal support.

The collaboration is multidisciplinary and involves clinicians, epidemiologists, statisticians and immunologists.</gtr:impact><gtr:outcomeId>G4YecyYUjJb-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input into my studies, collaborative meetings and discussions. Samples from Guinea Bissau being analysed in my lab in The Gambia, training of Guinea Bissau staff in my lab.</gtr:partnerContribution><gtr:piContribution>Training of lab staff and use of labaoratory facilities in The Gambia. Critical analysis of research proposals. Joint authroship on scientific papers. New collaborative projects written.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Statens Serum Institute (SSI)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Research Center for Vitamines and Vaccines (CVIVA)</gtr:department><gtr:description>CVIVA</gtr:description><gtr:id>43ED970F-DA1B-40BA-8689-26969E1C1F4D</gtr:id><gtr:impact>2 publications and 1 submitted</gtr:impact><gtr:outcomeId>aJ2UWVQfUBh-1</gtr:outcomeId><gtr:partnerContribution>Set up prospective randomised vaccine trials in Guinea-Bissau and Denmark</gtr:partnerContribution><gtr:piContribution>Intellectual input into study design, co-supervision of PhD student</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>13th NICS Meeting, 2012</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2CF38EFF-8F19-41C1-9920-958C6943071E</gtr:id><gtr:impact>Poster presentation of my research at the 13th National Immunization Conference in Darwin, Australia June 2012.

Further international exposure for my vaccine research</gtr:impact><gtr:outcomeId>N5rcZzGU7JN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sukuta Open Day 2010</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7DE55F30-E2C9-4D25-B740-FD80A549973C</gtr:id><gtr:impact>Open Day at field site where infant vaccine studies conducted. Attended by participant familes, local community, religious leaders, politicians. PI was interviewed about vaccine studies by local televison and press relase about the event was published in local newpapers.

Increased participation in ongoing studies, increased community acceptance of research activities.</gtr:impact><gtr:outcomeId>oDM8baaef6f</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ASID Annual Scientific Meeting 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B48A152C-1498-4289-9F0C-03C6FF799B4C</gtr:id><gtr:impact>I gave an oral presentation at the Australasian Society for Infectious Diseases 2012 Annual Scientific Meeting held in Freemantle, Perth, Australia in March 2012

New academic contacts in Infectious Diseases in Australia</gtr:impact><gtr:outcomeId>kp6bPnQ4erq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>7th World Congress of the World Society for Pediatric Infectious Diseases (WSPID)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B92AFA14-3693-43DE-A6A5-55E768016366</gtr:id><gtr:impact>I presented a poster at the meeting

New collaborations and further international recognition for the work</gtr:impact><gtr:outcomeId>PffwNpqNRnW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:description>Clifford Craig Medical Research Trust</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Clifford Craig Medical Research Trust</gtr:fundingOrg><gtr:id>510078C9-D5DE-4D73-BAAD-74B71B89F085</gtr:id><gtr:outcomeId>nrTNVqxE8fX</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>Denmark, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Grant for establishing Danish Research Centers of Excellence: Research Centre for Vitamins and Vaccines (CVIVA)</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Danish National Research Foundation (DNRF)</gtr:fundingOrg><gtr:id>33EDF99A-27F7-47B1-BC6B-1C33FF2C22EB</gtr:id><gtr:outcomeId>J47xrsvQJ3k</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1141331</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>NHMRC Project Grant</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1051228</gtr:fundingRef><gtr:id>D618F297-DBC9-4A90-98B7-10CFE63C0FC0</gtr:id><gtr:outcomeId>sye5FytajTB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6EC0AE56-C435-467F-8FE6-26A452C1B257</gtr:id><gtr:title>Heterologous (&amp;quot;nonspecific&amp;quot;) and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e16dca02a00616648b5fb16d77916ef0"><gtr:id>e16dca02a00616648b5fb16d77916ef0</gtr:id><gtr:otherNames>Flanagan KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_15868_28_23572484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDE1831D-2F71-40A3-8562-1817E2E357CA</gtr:id><gtr:title>Epidemiological studies of the non-specific effects of vaccines: II--methodological issues in the design and analysis of cohort studies.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d15216909c3a75a287e2e5f334f55f5e"><gtr:id>d15216909c3a75a287e2e5f334f55f5e</gtr:id><gtr:otherNames>Farrington CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>oxZ6bJmr189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7DD6303-B16F-4AB7-9EFA-95E3570211D1</gtr:id><gtr:title>Randomized trials to study the nonspecific effects of vaccines in children in low-income countries.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6344f04f5c29dcdb0ccde1feb25aed1"><gtr:id>a6344f04f5c29dcdb0ccde1feb25aed1</gtr:id><gtr:otherNames>Shann F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>HtsecE5i73x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C5948CB-C519-45EB-B172-C2AE6BB23437</gtr:id><gtr:title>The challenge of assessing infant vaccine responses in resource-poor settings.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e16dca02a00616648b5fb16d77916ef0"><gtr:id>e16dca02a00616648b5fb16d77916ef0</gtr:id><gtr:otherNames>Flanagan KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>TkzUtxFTk26</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F778074-02A7-4D8C-81D3-87C24D439159</gtr:id><gtr:title>Epidemiological studies of the 'non-specific effects' of vaccines: I--data collection in observational studies.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f2c755ca32ff67bc61f16d4f92b7574"><gtr:id>6f2c755ca32ff67bc61f16d4f92b7574</gtr:id><gtr:otherNames>Fine PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>hLeGkp7BYVL</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190088485</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>